Reported 33,985 shares, up 5,739 (20.3%) from the prior quarter.
Reported value -3.4%; share count 20.3% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 3162000 |
| 2022-03-31 | 3054000 |
| 2022-06-30 | 2969000 |
| 2022-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2022 | Reduced | 0 | -39,976 (-100.0%) | 0 | $0 | 2022-10-28 | |
| Q2 2022 | Added | 39,976 | +5,991 (17.6%) | 1.14% | $2,969,000 | 2022-08-08 | |
| Q1 2022 | Added | 33,985 | +5,739 (20.3%) | 0.99% | $3,054,000 | 2022-04-20 | |
| Q4 2021 | Added | 28,246 | +806 (2.9%) | 0.98% | $3,162,000 | 2022-01-26 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
794 managers reported SPDR SER TR SPDR S&P BIOTECH E for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | Added | 9,968,210 | +6,908,170 | 0.12% | $895,944,000 | 36 qtrs |
| Bank of America Corporation | Added | 6,111,848 | +1,743,954 | 0.05% | $549,333,000 | 36 qtrs |
| The Goldman Sachs Group Inc | Reduced | 5,701,763 | -2,381,440 | 0.11% | $512,475,000 | 36 qtrs |
| Citigroup Inc | Added | 4,039,027 | +398,170 | 0.22% | $363,027,000 | 36 qtrs |
| TORONTO DOMINION BANK | Reduced | 3,093,885 | -150 | 0.42% | $278,068,000 | 36 qtrs |
| Avoro Capital Advisors LLC | Added | 3,050,000 | +2,000,000 | 5.0% | $274,134,000 | 2 qtrs |
| Matrix Capital Management Company LP | New | 2,100,000 | +2,100,000 | 2.27% | $188,748,000 | 1 qtr |
| UBS Group AG | Reduced | 2,092,737 | -462,515 | 0.06% | $188,095,000 | 30 qtrs |
| Clal Insurance Enterprises Holdings Ltd | Added | 2,030,000 | +1,182,000 | 1.93% | $182,456,000 | 17 qtrs |
| Barclays PLC | Reduced | 1,452,640 | -485,399 | 0.1% | $130,563,000 | 36 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- April 20, 2022
- Filing type
- 13F-HR
- Position type
- S&P BIOTECH
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.